Tec/Btk tyrosine kinases are members of a subgroup of Src tyrosine kinase family. They are reported to be activated in response to cytokines, such as IL-3 and IL-6. Janus kinases (JAKs) are known to associate with certain cytokine receptors, e.g. gp130, the signal transducing subunit of IL-6 receptor, and the common b chain of IL-3 receptor, which can be activated upon receptor dimerization in response to cytokines. Here we show the association between Jak1/Jak2 and Tec or Jak1 and Btk. Furthermore, Jak1 but not Jak2 induces tyrosine phosphorylation of Btk, but not Tec. These observations suggest that upon cytokine stimulation JAKs activate Tec/Btk or induce their dimerization resulting in endogenous tyrosine phosphorylation. Furthermore using a yeast two-hybrid system we have identi®ed the target molecules for Tec, the p85 and p55PIK subunits of PI-3 kinase, and Vav. Tec associated with Vav through its SH2 domain independently of its kinase activity. In contrast the p85 and p55PIK subunits of PI-3 kinase associated with the SH2-kinase domain of Tec, dependent on Tec kinase activity. Consistent with these, IL-6 or IL-3 induced the association between Tec and the p85 subunit of PI-3 kinase in mammalian cells. These ®ndings suggest that Tec tyrosine kinase links cytokine receptors to PI-3 kinase probably through JAKs.
Introduction
Cytokines and growth factors exhibit a variety of biological functions through their speci®c receptors. Receptors for hematopoietic cytokines including interleukins (IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, , some of the colony stimulating factors (G-CSF and GM-CSF) and hormones (growth hormone and prolactin) do not have an endogenous consensus sequence for a protein kinase domain or any other known catalytic domain (Ihle, 1995) . These cytokine receptors display a certain degree of similarity in their extracellular domain, particularly with respect to their conserved cysteins and the WSXWS motif, they are thus de®ned as members of type I cytokine receptor superfamily (Bazan, 1990) . They also have a sequence similarity in the membrane proximal region of the cytoplasmic domain which contains conserved regions, termed as box1 and box2, and thought to be critical for signal transduction (Fukunaga et al., 1991; Ihle, 1995) . It was revealed that tyrosine kinase JAKs (Janus kinases) constitutively associate with box1 and box2 regions (Ihle, 1995; Tanner et al., 1995) . Upon ligand binding, JAK-associated receptors can dimerize and the associated kinase activities lead to the phosphorylation of tyrosine residues on the receptors and other signal transducing molecules (Ihle et al., 1995; Taniguchi, 1995) .
IL-6 is a typical pleiotropic cytokine with various biological functions. It plays a major role in the primary immune reaction and also displays various functions in liver, hematopoiesis, and nervous systems (Haegeman et al., 1986; Hirano et al., 1986; Zilberstein et al., 1986; Sehgal et al., 1989; Van Snick, 1990; Hirano, 1994) . The IL-6 receptor complex is composed of the ligand binding a subunit and the signal transducer gp130 (Yamasaki et al., 1988; Taga et al., 1989; Hibi et al., 1990) . The gp130 component is shared by the receptors for leukemia inhibitory factor, oncostatin M, IL-11, ciliary neurotrophic factor, and cardiotrophin1, indicating a possible common functional property with respect to intracellular signaling (Ip et al., 1992; Yin et al., 1993; Hirano et al., 1994; Pennica et al., 1995; Hibi et al., 1996) . It was shown that Janus kinases, Jak1, Jak2 and Tyk2 associate with the membrane proximal region of gp130 (Lutticken et al., 1994; Stahl et al., 1994) . The binding of IL-6 to the a receptor induces homodimerization of gp130 and subsequently the associated-JAK is autophosphorylated in addition to the tyrosine residues on gp130 and various signal tranducing molecules such as STATs (signal transducer and activator of transcription) and a protein tyrosine phosphatase SHP-2 (Murakami et al., 1993; Lutticken et al., 1994; Matsuda et al., 1994; Narazaki et al., 1994; Stahl et al., 1994 Stahl et al., , 1995 Fukada et al., 1996; Yamanaka et al., 1996) . On the other hand, the IL-3 receptor is composed of two components a and b, which is also shared by the receptors for IL-5 and GM-CSF (bc: the common b chain). The common b chain associates with Jak2, and upon the IL-3 stimulation it phosphorylates tyrosine residues on the bc chain and various signal transducing molecules including STAT5 (Sato et al., 1993; Mui et al., 1995) .
Since Hatakeyama et al. ®rst showed that the tyrosine kinase Lck associates with the b chain of IL-2 receptor, much evidence has been accumulated showing that several tyrosine kinases, besides JAKs, are activated by or associate with a variety of cytokine receptors (Hatakeyama et al., 1991; Taniguchi, 1995) . For example, the Src-type tyrosine kinase Hck was reported to associate with the carboxyl terminal region of gp130 and the activation of Hck is responsible to maintain the undierentiated states of embryonic stem cells in response to LIF (Ernst et al., 1994) . We demonstrated that Btk and Tec, which belong to a subgroup of Src-type tyrosine kinases, associate with and are activated by gp130 , although the physiological signi®cance of Btk/Tec in IL-6 signaling is yet to be elucidated fully.
Btk was originally identi®ed as a tyrosine kinase, the mutations of which are responsible for X-linked agammaglobulinemia (XLA) in human and X-linked immune de®ciency (Xid) in mouse Tsukada et al., 1993; Vetrie et al., 1993) . Physiologically Btk was shown to be involved in signaling of B cell antigen receptor (Saouaf et al., 1994) , Fc e receptor , CD38 (Santos Argumedo et al., 1995) , IL-5 (Sato et al., 1994) and IL-10 (Go et al., 1990) . Tec is known to be activated in response to stem cell factor (SCF) (Tang et al., 1994) , IL-3 (Mano et al., 1995) and erythropoietin (Machide et al., 1995) . The structural feature of Tec/ Btk tyrosine kinases is that they have a pleckstrin homology (PH) domain (Musacchio et al., 1993) and a Tec homology (TH) domain (Vihinen et al., 1994) in the amino terminal besides the SH2, SH3, and the tyrosine kinase domain. The PH domain is found in many various signal transducing molecules such as PLCg, Ras-GAP, Sos, Vav, serine/threonine kinase Akt etc. and is believed to be implicated in both proteinprotein interaction and lipid-protein interaction (Haslam et al., 1993; Musacchio et al., 1993; Ingley and Hemmings, 1994; Yao et al., 1994) . The TH domain contains a proline-rich motif and was shown to interact with various molecules including Fyn, Lyn and Hck through their SH3 domain in the case of Btk (Cheng et al., 1994) , and c-Kit, Lyn and Vav in the case of Tec Tang et al., 1994; Machide et al., 1995) . But the biological signi®cance of these interactions, or the roles of Tec/Btk in the cytokine receptor signaling remains to be elucidated.
To gain an initial insight into these issues, we undertook the identi®cation of the events downstream of Tec kinase. Here we show that Tec tyrosine kinase may work as connectors that link receptor-associated JAKs to various signal transducers including the p85, p55 PIK subunits of PI-3 kinase and Vav in the array of the cytokine signal transduction.
Results

Association of JAKs and Tec/Btk
We previously showed IL-6-mediated induction of tyrosine kinase activity of Tec and Btk in mouse IL-3 dependent pro-B cell line BAF-B03 cells expressing gp130 . To determine whether Tec or Btk associates with gp130 directly or indirectly, we employed a transient in vivo reconstitution system using the human embryonic kidney cell line, 293T cells. When we expressed alone in 293T cells, gp130 and Tec or Btk could not associate (Figure 3f for Tec, and data not shown for Btk), suggesting the putative involvement of some adaptor molecule(s) that could link gp130 to Tec/Btk. As reported previously, Janus kinases, Jak1, Jak2 and Tyk2, constitutively associate with gp130 in the membrane proximal region (Lutticken et al., 1994; Stahl et al., 1994) . We examined the possibility of JAK linking gp130 to Tec/Btk protein. In the human hepatoma cell line HepG2, Tec was tyrosine phosphorylated in response to IL-6 (Figure 1, left panel) . In HepG2 cells, a number of tyrosine phosphorylated proteins could be detected in Tec immunoprecipitate (Figure 2, left panel) . One of protein band comigrated with Jak1 in a SDSpolyacrylamide gel, suggesting that Jak1 associates with Tec. We could also detect the association of a Jak2-comigrated tyrosine phosphorylated protein in Tec immunoprecipitate in BAF-B03 cells (Figure 2 , right panel), in which Tec was tyrosine phoshphorylated in response to IL-3 (Figure 1, right panel) . As shown in Figure 3a , when Jak2 or Jak1 was expressed together with Tec in 293T cells, we could observe a distinct tyrosine phosphorylated protein corresponding to Jak2 (lane 7) or Jak1 (lane 13) in Tec immunopre- 7 BAF-B03 cells (right panel) were stimulated with human IL-6 (100 ng/ml) or IL-3 (10 ng/ml) for 10 min (+) or left unstimulated (7). Jak1, Jak2 and Tec were immunoprecipitated (IP) with respective speci®c antibodies. Their tyrosine phosphorylation or co-precipitated proteins were detected by immunblotting (Blot) with anti-phosphotyrosine antibody. The locations of Jak1 (left panel) and Jak2 (right panel) are indicated by the arrows cipitates, suggesting that Tec directly associated with either Jak2 protein or Jak1. The interactions were also observed when Jak2 or Jak1 was expressed with a kinase negative mutant of Tec (TecKN: mutated in its ATP binding region, lanes 9 and 15). In the case of Btk when Jak1 was expressed together with Btk or its kinase negative mutant (BtkKN: mutated in its ATP binding region) in 293T cells, we observed a tyrosine phosphorylated protein corresponding to Jak1 in Btk or BtkKN immunoprecipitates (Figure 3b , lanes 7 and 9) and a phosphorylated protein corresponding to Btk in Jak1 immunoprecipitate (lane 8), suggesting the association between Jak1 and Btk, although we could not observe the association of Jak2 and Btk (lanes 13 and 14). Co-immunoprecipitation of Jak1 with Tec or Btk was further con®rmed by immunoblotting with antibodies which directly recognized Jak1 proteins (Figure 3c, lanes 5 and 11) . Approximately 5% of Jak1 protein was co-precipitated with Tec or Btk. Btk, but not its kinase negative mutant (BtkKN: mutated in its ATP binding region) was autophosphorylated when expressed in 293T cells (Figure 3b 
Tec interacts with the p85, p55 subunits of PI-3 kinase and Vav
To explore downstream molecules of Tec tyrosine kinase, we employed a yeast two-hybrid system. We constructed a full open reading frame of Tec fused to the DNA binding domain of a yeast transcriptional factor GAL4. Using the GAL4-Tec fusion protein as a bait, a human B cell cDNA library which expresses cDNA products as fusion proteins with the GAL4 activation domain was screened and 12 clones from ®ve million transformants were selected. One clone (T12) was highly homologous (93.8% identical at the amino acid level) to bovine p85b subunit of PI-3 kinase, thus it was assigned to be human p85b subunit. The clone (T14) was identical (96.9%) to mouse p55PIK subunit of PI-3 kinase, and was assigned to be human p55PIK subunit. p55PIK was originally identi®ed as a component of PI-3 kinase which can bind IRS-1 in response to insulin (Pons et al., 1995) . p55PIK has a strong amino acid sequence homology with the p85 subunit. Both the cDNA fragments of the p85b and p55PIK contained in their respective carboxyl terminal SH2 domains (Figure 4a ). Two clones (T47 and T89) were superimposed and turned out to be fragments of the cDNA for Vav (Figure 4a ). The association between Tec and these molecules was speci®c, and their interactions were also detected when the inserts were exchanged into each other between the GAL4 DNA binding domain and the activation domain vectors (Figure 4b ).
Tec associates with p85, p55 and Vav through its dierent domains
To de®ne the Tec domains interacting with the p85 and p55 subunits of PI-3 kinase and Vav proteins, various deletion mutants of these molecules were constructed and examined for the interaction using the two-hybrid system by detecting the b-galactosidase activity. As shown in Figure 5 , the minimal region which could interact with the p85 subunit contained the SH2 and the kinase domains (construct 9). The regions required for Tec to associate with the p55PIK were identical to that of the p85. As shown in Figure 4a , the fragments of p85 (T12) and p55PIK (T14) contained a SH2 domain which is known to recognize and bind phosphotyrosines in the YXXM peptide motif (Carpenter et al., 1993; Songyang et al., 1993; Cantley and Songyang, 1994) . In the two-hybrid system, the DNA binding domain of GAL4 can dimerize with itself. Therefore it is possible that Tec fused to the GAL4 DNA binding domain is dimerized and phosphorylates itself in a similar manner as homodimerization of the cytokine receptors, resulting in phosphorylation of Tec. To reveal whether the binding of the p85 and p55 to Tec depend on the phosphorylation of Tec, we used the kinase negative mutant of Tec which was defective in autophosphorylation when expressed in 293T cells (Figure 3a , lane 3). The kinase negative mutant of Tec ( Figure 5 , construct 16) could not associate with either the p85 or p55, suggesting that SH2 domains of the p85 and p55 bind phosphoptyrosines in the Tec kinase domain. On the other hand, the minimal region which could interact with Vav contained either the SH3 and the SH2 ( Figure 5, construct 8) , or the SH2 and the kinase domains (construct 9). Both regions contained the SH2 domain, suggesting that the SH2 domain is required for the association and either the SH3 or the kinase domain could support the intermolecular interaction. These data reveal that Tec utilizes dierent portions to associate with its target molecules.
Cytokine-dependent association of Tec and PI-3 kinase in vivo
The association between Tec and Vav in mammalian cells was reported previously (Machide et al., 1995) and thus we focused on the association between Tec and PI-3 kinase in vivo in mammalian cells. When Tec and the p85 subunit of PI-3 kinase were expressed together in 293T cells, Tec and the p85 were detected in the p85 and the Tec immunoprecipitates, respectively, indicating that they can associate with each other in mammalian cells (Figure 6a ). However, the interaction 6 cells in 100 mm dish) were transfected with the expression vectors for wild-type Tec (lanes 1 and 2), a kinase negative form of Tec (TecKN: lysine 397 of Tec in the ATP binding site is mutated to glutamate, lanes 3 and 4), Jak2 (lanes 5 and 6), Jak2 and Tec (lanes 7 and 8), Jak2 and TecKN (lanes 9 and 10), Jak1 (lanes 11 and 12), Jak1 and Tec (lanes 13 and 14), or Jak1 and TecKN (lanes 15 and 16). Seventy-two hours after transfection, cells were harvested and cell lysates were immunoprecipitated with either anti-Tec antibody (lanes 1, 3, 5, 7, 9, 11, 13 and 15), anti-Jak2 antibody (lanes 2, 4, 6, 8 and 10), or anti-Jak1 antibody (lanes 12, 14 and 16). Tyrosine phosphorylated proteins or Tec expression were detected by blotting with antiphosphotyrosine antibody (upper panel) and anti-Tec antibody (lower panel), respectively. The arrows indicate the locations of Jak2, Jak1 and Tec. Tec proteins co-precipitated with Jak1 or Jak2 were not detected by either anti-phosphotyrosine or anti-Tec antibody in this exposure due to the low stoichiometry of their association. Co-precipitation of Tec with Jak1 was shown in (c) and (e) in a long exposure. (b) Interaction of Jak1/Jak2 and Btk. 293T cells were transfected with the expression vectors for wild-type Btk (lanes 1 and 2), a kinase negative mutant of Btk (BtkKN: lysine 430 of Btk is mutated to glutamate, lanes 3 and 4), wild-type Jak1 (lanes 5 and 6), Jak1 and Btk (lanes 7 and 8), Jak1 and BtkKN (lanes 9 and 10), Jak2 (lanes 11 and 12), or Jak2 and Btk (lanes 13 and 14). Seventy-two hours after transfection, proteins were immunoprecipitated with either anti-Btk antibody (lanes 1, 3, 5, 7, 9, 11 and 13), anti-Jak1 antibody (lanes 2, 4, 6, 8 and 10), or anti-Jak2 antibody (lanes 12 and 14) and separated on SDSpolyacrylamide gel. Tyrosine phosphorylated proteins and Btk were stained with anti-phosphotyrosine antibody (upper panel) and anti-Btk antibody (lower panel), respectively. The locations of Jak1, Jak2 and Btk are indicated by the arrows. (c) Jak1 associates with Tec or Btk in 293T cells. 293T cells transfected with expression vectors for Tec (lanes 1 and 2), Jak1 (lanes 3, 4, 9 and 10), Jak1 and Tec (lanes 5 and 6), Btk (lanes 7 and 8), Jak1 and Btk (lanes 11 and 12) were lysed and immunoprecipitated with anti-Tec antibody (lanes 1, 3 and 5), anti-Btk antibody (lanes 7, 9 and 11), or anti-Jak1 antibody (lanes 2, 4, 6, 8, 10 and 12). Jak1 protein was stained with anti-Jak1 antibody. The location of Jak1 was indicated by the arrow. 1, 2, 3 and 4) and anti-Jak1 antibody (lanes 5 and 6) and their tyrosine phosphorylation and expression were detected by immunoblotting with anti-phosphotyrosine antibody (upper panel), and anti-Btk was not observed when the kinase negative form of Tec was expressed with the p85 (Figure 6a) . Consistent with the results obtained from the yeast two-hybrid system, their association was dependent on the kinase activity of Tec, suggesting that the association takes place when Tec is activated and phosphorylated in response to cytokines. In HepG2 cells, IL-6 induced tyrosine phosphorylation of Jak1 and Tec (Figure 1 , left panel and Figure 2, left panel) . We detected the p85 subunit of PI-3 kinase in Tec immunoprecipitate but not in Jak1 or Jak2 immunoprecipitates when HepG2 cells were stimulated by IL-6 (Figure 6b, upper  panel) . In BAF-B03 cells, we also detected the p85 coimmunoprecipitated with Tec only in IL-3-stimulated cells (Figure 6b, lower panel) . These data clearly indicate that the interaction of Tec and PI-3 kinase is dependent on the cytokine stimulation.
Discussion
In this report we demonstrated the association of Tec and Btk with JAKs in intact cells. Most cells responsive to IL-6 express Tec tyrosine kinase, but not Btk, whose expression is limited to hematopoietic cells. Therefore Tec is likely to be involved in the IL-6 signaling in various tissues. We observed the interaction of JAKs and Tec in HepG2 cells and BAF-B03 cells. Their interaction was also observed in the transient expression system using 293T cells even though a kinase negative mutant of JAK was expressed. We previously reported that Btk and Tec constitutively associate with gp130 and were activated by the ligand-mediated gp130 stimulation in BAF-B03 cells expressing gp130 . However, the association of gp130 and Tec or Btk required the presence of JAK in the transient expression system, suggesting that their interaction is not direct but mediated by JAKs which constitutively associate with gp130.
Tyrosine phosphorylation of Tec and Btk was observed in transient expression system using 293T cells, probably they could be aggregated due to high expression levels of the molecules, resulting in autologous transphosphorylation. This is supported by the absence of tyrosine phosphorylation of Tec and Btk when the kinase negative mutants were expressed. Interestingly, the kinase negative mutant of Btk was phosphorylated by the co-expression with Jak1 but not with Jak2, suggesting that Btk is a direct substrate of Jak1. Similar results were reported when Btk was expressed with the Src tyrosine kinase, Btk was phosphorylated and activated (Mahajan et al., 1995; Rawlings et al., 1996) . It was reported that tyrosine 551 of Btk is phosphoacceptor site for the Src tyrosine kinases and its mutation eliminates the Btk kinase activity (Rawlings et al., 1996) . In antigen receptor signaling in B lymphocytes, various Src-type tyrosine kinases such as Fyn, Lyn and Blk are believed to be involved and may act as activators for Btk (Saouaf et al., 1994) . In the cytokine receptor signaling, JAKs might execute a similar function as the Src-type tyrosine kinases. The precise mapping of phosphoacceptor sites on Btk by JAK1 or the cytokine stimulation is necessary to elucidate this point. In the case of Tec, the phosphorylation of the kinase negative mutant of Tec was not induced by either Jak1 or Jak2, or the phosphorylation of Tec was not enhanced by the JAK expression. Although the stoichiometry of the interaction between JAKs and Tec (Figure 2a, c and e) was not high, it would be due to the condition of immunoprecipitation. It is possible that Tec is anchored by the cell membrane through its PH domain (Lemmon et al., 1996) and its aggregation in the membrane proximal area can be induced by JAK dimerization despite its weak interaction with JAK. The aggregation of JAK following the receptor dimerization might increase the local concentration of Tec close to the membrane, resulting in the autologous transphosphorylation of Tec.
We employed the yeast two-hybrid system in order to ®nd the putative targets of Tec. Three dierent molecules (the p85 and p55 subunits of PI-3 kinase and Vav) were identi®ed, moreover, the regions required for Tec to associate with these molecules were also identi®ed. Vav was previously reported to associate with Tec through the TH domain, and the association was reported to be increased following the erythropoietin stimulation (Machide et al., 1995) . We assigned the binding portion for Vav as the SH2 domain using the yeast two-hybrid system, but, could not obtain evidence for the interaction of the TH domain and Vav. The reported data for the TH domain-Vav interaction was obtained with the use of GST fusion protein. As reported, the proline-rich motif in TH domain can bind the SH3 domain of various Src-type tyrosine kinases in vitro (Cheng et al., 1994; Alexandropoulos et al., 1995; Yang et al., 1995) . It is possible that the SH3 domains of Vav interact with the TH domain of Tec to support the interaction of the SH2 domain of Tec and Vav. We previously showed that the gp130 stimulation induced tyrosine phosphorylation of Vav . Vav may be phosphorylated by Tec tyrosine kinase.
We also obtained two related molecules the p85b and p55PIK subunits of PI-3 kinase. The interaction of antibody or anti-Jak1 antibody (lower panel), respectively. Similar levels of expression of Jak1, Jak1KN and Jak2 in their transfectants (lanes 2, 3 and 4) was detected (data not shown). The arrows indicate the location of Btk and Jak1. (e) Association of Jak1 and Tec is independent of the kinase activity of Jak1. 293T cells were transfected with expression vectors for hemagglutinin (HA)-tagged Tec (HATec, lanes 1 and 2), Jak1 (lanes 3 and 4), Jak1KN (lanes 5 and 6), the combination of Jak1 and HA-Tec (lanes 7 and 8), or Jak1KN and HATec (lanes 9 and 10). Cell lysates were immunoprecipitated with anti-HA antibody (lanes 1, 3, 5, 7 and 9) or anti-Jak1 antibody (lanes 2, 4, 6, 8 and 10). Immunoprecipitated or co-precipitated HA-Tec was detected by immunoblotting with anti-HA antibody. The arrow indicates the position of HA-Tec. (f) gp130 associates with Tec though Jak1 in 293T cells. 293T cells were transfected with expression vectors for gp130 and Tec (lanes 1 ± 3), Jak1 and Tec (lanes 4 ± 6), or gp130, Jak1, and Tec (lanes 7 ± 9). Cell lysates were immunoprecipitated with anti-gp130 antibody (G, lanes 1, 4 and 7), anti-Jak1 antibody (J, lanes 2, 5 and 8), or anti-Tec antibody (T, lanes 3, 6 and 9) . Immunoprecipitated or co-precipitated Tec proteins were detected by immunoblotting with anti-phosphotyrosine antibody. The arrow indicates the position of Tec. Tec was also detected by an antibody that directly recognizes Tec protein (data not shown) Tec and the p85b or p55PIK needed the kinase activity of Tec both in the yeast two-hybrid system and in the transient expression system using 293T cells. Consistent with these, Tec interacted with p85 in native cells in the stimulation dependent manner. These observations suggest that PI-3 kinase interacts with Tec through phosphotyrosine residue(s) (possibly tyrosine 594, ®tting the consensus sequence, YXXM, for the p85 SH2 binding) of Tec and the SH2 domain of the p85 or p55PIK subunit. PI-3 kinase was reported to be activated through the direct interaction between phosphorylated cytokine receptor and the p85 subunit (accession number D84510) and T14 (D84511) were identical to those of bovine p85b (93.8% identical at the amino acid level) and mouse p55PIK (96.9% identical) subunits of PI-3 kinase. The small dierences between clones and published data are most likely due to species' dierence (p85b is bovine-and p55PIK is mouse-derived). The nucleotide sequences of clones T47 and T89 are completely identical to that of Vav. Thick bars represent inserts of these clones and the indicated numbers are the ®rst and last amino acids of the proteins encoded by the cDNA inserts, corresponding to the original published clones. Structural motifs were shown in p85b, p55PIK, and Vav proteins. The abbreviations stand for leucine-rich region (LR), acidic domain (AD), Dbl-homologous domain (DblH), pleckstrin homology motif (PH), zinc ®nger-like cysteine rich region (CR), Src homology 2, 3 (SH2, SH3), inter SH2 domain (I-SH2), BCR homology region (BCR), and proline-rich motif (PR). (b) Speci®city of the interactions. Speci®c interaction of Tec and p85, p55PIK or Vav was examined by two-hybrid system. The full open reading fragment of Tec and the obtained clones (T12 for p85, T14 for p55PIK and T89 for Vav) were used to construct the expression vectors that express GAL4 DNA binding domain (DBD) fusion protein (pAS2) or GAL4 activation domain (ACT) fusion protein (pACT or pACT2). Yeast strain Y190 was transformed with the indicated combinations of the plasmid. Transformed yeast cells are streaked on an agar plate of synthetic dextrose lacking uracil, tryptophan, and leucine. The association was determined by the X-gal ®lter assay, described in Materials and methods. After 2 h incubation with 1 mg/ml of X-gal, their b-galactosidase activities were determined as + for blue (represents more than 0.5 unit) and 7 for white. The data was obtained from four independent transformant colonies Figure 5 Binding region of Tec for p85, p55 and Vav. Various portions (constructs 1 ± 15, PH: amino acid 1 ± 122, TH: 116 ± 180, SH3: 176 ± 253, SH2: 249 ± 348, KD: 351 ± 630) or a kinase negative mutant (construct 16) of Tec were inserted into the GAL4 DBD fusion vector (pAS2). Y190 yeast cells were transformed with these Tec constructs and GAL4 ACT fusion vectors expressing p85, p55 and Vav (identical to T12, T14 and T89, respectively). The association was determined by the X-gal ®lter assay. The strength of the b-galactosidase activity was indicated as +++ for the appearance of blue color within 30 min, ++ for within 2 h and + for within 6 h, and 7 for the lack of color development at the 6 h time point. ND stands for not determined' in the case of erythropoietin receptor (He et al., 1993; Miura et al., 1994) and IL-4 receptor (Wang et al., 1992) , through an unidenti®ed adaptor molecule (p80) associated with the receptors for IL-3, GM-CSF family cytokines (Jucker and Feldman, 1995) , or through Jak3 associated with IL-7 receptor (Sharfe et al., 1995) . We demonstrated that PI-3 kinase could be activated by Tec. This is a new mechanism by which type I cytokine receptor activates PI-3 kinase.
PI-3 kinase is thought to be implicated in various biological eects such as mitogenic signals (Whitman and Cantley, 1989; Valius and Kazlauskas, 1993; Jhun et al., 1994) , membrane ruing Wennstrom et al., 1994) , oxidative burst (Arcaro and Wymann, 1993) , glucose transport (Okada et al., 1994; Hara et al., 1994; Kotani et al., 1995; Tsakiridis et al., 1995) etc. The biochemical targets of PI-3 kinase for these signals have not been clearly described. In the case of mitogenic signals, PI-3 kinase was reported to act either between the receptor and Ras, or downstream of Ras in PDGF signaling (Rodriguez-Viciana et al., 1994; Hu et al., 1995) . Phosphatidylinositol triphosphate, PI (3, 4, 5)-P3, was also shown to modulate the association of phosphotyrosine (pY)-containing protein and SH2 domains (Rameh et al., 1995) . There are many pY and SH2 interactions implicated in IL-6 signals, such as the interactions of gp130-SHP-2 and gp130-STAT3 Fukada et al., 1996) . PI (3,4,5)-P3 may attenuate these interactions as it works as a feedback mechanism. PI (3,4,5)-P3 was also known to activate various serine/ threonine kinases including nPKC (Toker et al., 1994) , aPKC (Nakanishi et al., 1993) (n: novel and a: atypical against c: conventional PKC), Akt (Franke et al., 1995) , JNK (Klippel et al., 1993) and p70 S6 kinase (Cheatham et al., 1994; Monfer et al., 1995) . In IL-6 signals, a H7-sensitive serine/threonine kinase is involved in the activation of Stat3 besides its tyrosine phosphorylation Nakajima et al., 1995; Zhang et al., 1995) . These PI (3,4,5)-P3 dependent kinases might be implicated in the serine phosphorylation of STAT3.
We demonstrated that Tec tyrosine kinase plays a role in transmitting signals from the IL-3 and IL-6 receptors to PI-3 kinase. This pathway, in combination with JAK-STAT pathway, may generate a complexity of biological functions of the cytokines. Furthermore Tec-PI-3 kinase pathway may be involved in signaling through not only cytokines but also B cell antigen receptor, FceR, and CD38.
Materials and methods
Cell culture and transfections
293T is a cell line established by transforming a human embryonic kidney cell line 293 with the SV40 large T antigen. HepG2 and 293T cells were grown in Dulbecco's Modi®ed Eagles Medium (DMEM, GIBCO) with 10% fetal calf serum (FCS), 100 units/ml penicillin and 100 mg/ ml streptomycin. IL-3 dependent murine pro-B cell line, BAF-B03 cells were maintained in RPMI 1640 medium (GIBCO) supplemented with 10% FCS and 10% conditioned medium from WEHI-3B cells as a source of IL-3. HepG2 cells were starved in serum-free DMEM for 5 h and treated with or without 100 ng/ml of human recombinant IL-6 (kindly provided from Ajinomoto Co.) for 10 min. BAF-B03 cells were starved in the medium lacking WEHI-3B conditioned medium for 15 h and treated with or without 10 ng/ml of IL-3 (prepared from the supernatant of CHO cells transfected with IL-3 cDNA kindly provided by Dr Sudo) for 10 min.
For the transient transfection, 293T cells grown subconuently in a 100 mm dish (approximately 1610 6 cells) were transfected with 2 mg of each expression vector plasmid by standard calcium phosphate precipitation method. Seventytwo hours after transfection, cells were harvested and subjected to further analysis.
Antibodies
Rabbit antibodies against Tec, Btk, Jak1, Jak2 and rat monoclonal antibody against gp130 were previously described . Anti-p85 antibody 7 BAF-B03 cells (lower panel) were stimulated with IL-6 and IL-3, respectively, for 10 min (+) or left unstimulated (7). Cell lysates were immunoprecipitated with anitbodies speci®c for Jak1, Jak2, Tec or p85. p85 was detected by immunoblotting with anti-p85 antibody. The location of p85 is indicated by the arrow and an anti-phosphotyrosine monoclonal antibody, 4G10 were purchased from UBI (Lake Placid, NY). A monoclonal antibody for the hemagglutinin epitope, 12CA5 was from Boehringer Mannheim Co. Anti-Myc epitope antibody was purchased from Genosys Biotechnologies Inc.
Plasmid construction
Expression vectors for Jak1, Jak2, Tec, Btk and their kinase negative mutants were constructed in pEFBOS (a gift from Dr Nagata). Jak1 and Jak2 cDNA fragments were excised by XbaI and EcoRV from pCDM8-SRa Jak1 and pCDM8-SRa Jak2 (gifts from Drs Shibuya and Taniguchi) and subcloned into pBluescript SK + (Strategene, pBluescript-Jak1). Lysine 895 in the ATP binding site of Jak1 was mutated to glutamate (Jak1KN) by sitedirected mutagenesis using a two step PCR protocol. The Eco47 ± BglII fragment of Jak1, which contains lysine 895, was replaced by the same fragment derived from Jak1KN (pBluescript-Jak1KN). pEFBOS Jak1 and pEFBOS Jak1KN were constructed by insertion of the XbaI ± EcoRV fragments excised from pBluescript-Jak1 andJak1KN into BstXI sites of pEFBOS after blunting and BstXI adaptor (Invitrogen) ligation. To construct pEF-BOS-Tec and pEFBOS-Btk, Tec and Btk fragments were excised from pSRaTec (a gift by Dr Mano) and MSVSRatkNeo-Btk (a gift from Drs Tukada and Witte) by XbaI/EcoRI and XhoI/NotI respectively, subsequently blunted by T4 polymerase and ligated into BstXI sites of pEFBOS with BstXI adaptor. Kinase negative mutants of Tec (TecKN) and Btk (BtkKN) were constructed by mutations of lysine 397 in Tec and lysine 430 in Btk to glutamates by the PCR-mediated site-directed mutagenesis. Hemagglutinin (HA)-tagged Tec was constructed by insertion of a coding fragment of Tec in which the translation initiation sites were mutated to a NcoI site by PCR into pBluescript-3xHA-JNK1, a derivative of pSRaJNK1 (DeÂ rijard et al., 1994) . The expression vector for HA-tagged Tec was constructed by insertion of HAtagged Tec fragment into HindIII/XhoI sites of pcDNA3 (Invitrogen). The expression vector for mouse gp130 was previously described (Saito et al., 1992) . To construct the expression vector for the p85a subunit of PI-3 kinase, a Myc epitope was generated at the carboxy terminal of bovine p85a subunit by the PCR-mediated method (Squinto et al., 1990) . The fragment of p85a-Myc cDNA was subcloned into EcoRI/ApaI sites of pcDNA3 (pcDNA3-p85aMyc).
Two-hybrid vectors were constructed in a yeast GAL4 DNA binding domain fusion vector pAS2 or a GAL4 activation domain vector pACT2. A BamHI site was generated prior to the initiation codon based on pSRa-Tec plasmid by PCR, and the fragment of an entire coding fragment of Tec was excised by BamHI and EcoRI, and subcloned into pBluescript SK + (Strategene, pBluescriptTec). pAS2-Tec (full length) was constructed by the BamHI ± SalI fragment excised from pBluescript-Tec and subcloned into pAS2. To exchange the cDNA fragments (p85, p55 and Vav) of pACT obtained from the screening to pAS2 vector, their XhoI fragments were subcloned into SalI site of pAS2. Various fragments of Tec were generated from pSRa-Tec by PCR and subcloned into NcoI/BamHI sites or NdeI/BamHI sites (depends on the restriction sites on the primers) of pAS2. To construct pAS2-TecKN (kinase negative), the KpnI ± EspI fragment of Tec was replaced by the same fragment derived from pEFBOS-TecKN. Control vectors for p53 (pAS-p53) is a gift from Dr S Elledge. Primers used for PCR were available on the request. PCR was performed by Pfu polymerase (Strategene) and the PCR products were con®rmed by DNA sequencing using Thermosequenase (Amersham) and ALF automated sequencer (Pharmacia).
Immunoprecipitation and immunoblotting
After stimulation, BAF-B03 or HepG2 cells were lysed in the lysis buer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% NP40, 1 mM sodium vanadate, 5 mg/ml aprotinin and 5 mg/ml pepstatin). Cell lysate was cleared by centrifugation at 10 000 g for 30 min, then incubated with 5 ml of polyclonal antibodies (antisera against Jak1, Jak2, Btk, Tec or p85), or 5 mg of monoclonal antibodies (antibody against HA or Myc epitope) for 4 h at 48C and with 10 ml of protein A sepharose beads for 1 h. After washing the beads with 1 ml of the lysis buer in the absence of protease inhibitors ®ve times, proteins were eluted with Laemli's SDS sample buer and separated by 4 ± 20% gradient SDS-polyacrylamide gel. Proteins were transfered onto PVDF membranes (Immobilon P, Millipore) and membranes were incubated with one thousand times diluted antisera or 5 mg/ml of monoclonal antibodies. After washing with TBST (20 mM Tris-HCl pH 7.4, 150 mM NaCl and 0.1% Tween 20) three times, membranes were incubated with horse radish peroxidaseconjugated goat anti-rabbit (for antisera) or anti-mouse (for anti-HA antibody) antibody for 1 h at room temperature. After washing, immune complexes were visualized by chemiluminescence system (Renaissance, DuPont).
Yeast two-hybrid system
Yeast transformation and screening procedure was principly described previously (Durfee et al., 1993; Harper et al., 1993) . Brie¯y Saccharomyces cerevisiae Y190, harboring GAL4-dependent HIS3 and b-galactosidase reporter genes in its yeast genome, were transformed with pAS2-Tec plasmid by the modi®ed lithium acetate method (Schiestl and Gietz, 1989) . Tranformants were selected by agar plates of synthetic dextrose (SD) lacking uracil and tryptophan and grown in the same medium. Then they were retransformed with 40 mg of cDNA library plasmid for each transformation and plated on agar plates of SD minus uracil, tryptophan, leucine and histidine but containing 100 mM 3-aminotriazole for selection or SD minus uracil, tryptophan and leucine for checking transformation eciency. Five days after the transformation, positive colonies grown in the selection plates were subjected to a X-gal ®lter assay to detect b-galactosidase activity. Clones positive for both assays (His selection and b-galactosidase assay) were subjected to further analysis. Plasmid DNAs derived from pACT cDNA library were recovered from yeast cells and were ampli®ed in E. coli. Their cDNA inserts were further characterized by restriction digestion and DNA sequencing. Sequence comparisons were performed by the program FASTA.
